About Enhancer
| Enhancer ID: | E_02260 |
| Species: | Homo sapiens |
| Position : | chr20:20392790-20394473   |
| Year: | 2025 |
| Title: | NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | neuroendocrine prostate cancer |
| PMID: | 40691407 |
| MONDO: | MONDO:0002477 |
| Tissue: | cervical lymph node |
| Tissue Ontology ID: | UBERON:0002429 |
| Cell Source: | NCI-H660 |
| CVCL ID: | CVCL_1576 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Chromatin interaction assay; Regulatory element annotation |
| High Throughput Method: | Hi-C; H3K27ac ChIP-seq; H3K27me3 ChIP-seq; RNA-seq |
| Low Throughput Method: | 3C |
About Target Gene
| Target gene : | INSM1 |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer